Polycystic ovarian syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: The first group: recipients of clomiphene citrate with a dose of 50 to 150 mg from the day of the 3rd cycle to 3 months after ovulation + placebo daily until pregna
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Age 20 to 35 years Body mass index less than 30 kg/m2 Suffering from the polycystic ovary, according to Rotterdam criteria
Exclusion criteria
Exclusion criteria: Other causes of infertility Male factor Abnormal thyroid function tests Abnormal prolactin levels Diabetes Anatomical disorder in hysterosalpingography or laparoscopy Endometriosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ovulation induction. Timepoint: On the 14th day of the menstrual cycle and Every day for the next two weeks. Method of measurement: Serum levels of human chorionic gonadotropin. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pregnancy. Timepoint: Day 14 of the cycle. Method of measurement: Transvaginal ultrasound.;Do Quitos. Timepoint: Three times a week. Method of measurement: Transvaginal ultrasound.;Measurement of human chorionic gonadotropin-beta serum level. Timepoint: two weeks later. Method of measurement: Serum test.;Gestational sac. Timepoint: Six weeks later. Method of measurement: Transvaginal ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLiravi Hosna
Sanandaj University of Medical Sciences
Outcome results
None listed